224 related articles for article (PubMed ID: 19105235)
21. Coamplification of 3-hydroxy-3-methylglutaryl coenzyme A reductase genes in methotrexate-resistant human leukemia cell lines.
Srimatkandada S; Dube SK; Carmen M; Bertino JR
Oncol Res; 2000; 12(1):11-5. PubMed ID: 11061341
[TBL] [Abstract][Full Text] [Related]
22. The establishment and characterization of adriamycin-resistant cell lines derived from Saos-2.
Niu BH; Wang JJ; Xi Y; Ji XY
Med Sci Monit; 2010 Jun; 16(6):BR184-92. PubMed ID: 20512087
[TBL] [Abstract][Full Text] [Related]
23. Establishment of new multidrug-resistant human osteosarcoma cell lines.
Oda Y; Matsumoto Y; Harimaya K; Iwamoto Y; Tsuneyoshi M
Oncol Rep; 2000; 7(4):859-66. PubMed ID: 10854558
[TBL] [Abstract][Full Text] [Related]
24. Distinct sequences on 11q13.5 and 11q23-24 are frequently coamplified with MLL in complexly organized 11q amplicons in AML/MDS patients.
Zatkova A; Ullmann R; Rouillard JM; Lamb BJ; Kuick R; Hanash SM; Schnittger S; Schoch C; Fonatsch C; Wimmer K
Genes Chromosomes Cancer; 2004 Apr; 39(4):263-76. PubMed ID: 14978788
[TBL] [Abstract][Full Text] [Related]
25. Single-nucleotide polymorphism profiling by multimodal-targeted next-generation sequencing in methotrexate-resistant and -sensitive human osteosarcoma cell lines.
Casotti C; Hattinger CM; Patrizio MP; Luppi S; Fantoni L; Pasello M; Scotlandi K; Ibrahim T; Serra M
Front Pharmacol; 2023; 14():1294873. PubMed ID: 38074116
[No Abstract] [Full Text] [Related]
26. Gene amplification and expression in lung cancer cells with acquired paclitaxel resistance.
Yabuki N; Sakata K; Yamasaki T; Terashima H; Mio T; Miyazaki Y; Fujii T; Kitada K
Cancer Genet Cytogenet; 2007 Feb; 173(1):1-9. PubMed ID: 17284363
[TBL] [Abstract][Full Text] [Related]
27. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
[TBL] [Abstract][Full Text] [Related]
28. A new myeloblastic leukemia cell line with double minute chromosomes. Induction of methotrexate resistance and dihydrofolate reductase gene amplification.
Saito H; Kishi K; Narita M; Furukawa T; Nagura E; Maekawa T; Abe T; Shibata A
Leuk Res; 1992; 16(3):217-26. PubMed ID: 1560671
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells.
Song B; Wang Y; Titmus MA; Botchkina G; Formentini A; Kornmann M; Ju J
Mol Cancer; 2010 Apr; 9():96. PubMed ID: 20433742
[TBL] [Abstract][Full Text] [Related]
30. Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cells.
Tornín J; Gallego B; Rey V; Murillo D; Huergo C; Rodríguez A; Canal C; Rodríguez R
Free Radic Biol Med; 2023 Nov; 209(Pt 1):127-134. PubMed ID: 37844652
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.
Susa M; Iyer AK; Ryu K; Choy E; Hornicek FJ; Mankin H; Milane L; Amiji MM; Duan Z
PLoS One; 2010 May; 5(5):e10764. PubMed ID: 20520719
[TBL] [Abstract][Full Text] [Related]
32. [Study on the genetic alterations in MTX-resistant cells by differential polymerase chain reaction].
Zhang Y; Deng XY; Zhang XL; Zhang GY; Li P; Fu SB
Yi Chuan Xue Bao; 2003 Apr; 30(4):321-4. PubMed ID: 12812055
[TBL] [Abstract][Full Text] [Related]
33. Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines.
Mensah-Osman EJ; Thomas DG; Tabb MM; Larios JM; Hughes DP; Giordano TJ; Lizyness ML; Rae JM; Blumberg B; Hollenberg PF; Baker LH
Cancer; 2007 Mar; 109(5):957-65. PubMed ID: 17279585
[TBL] [Abstract][Full Text] [Related]
34. Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells.
Meng X; Qi X; Guo H; Cai M; Li C; Zhu J; Chen F; Guo H; Li J; Zhao Y; Liu P; Jia X; Yu J; Zhang C; Sun W; Yu Y; Jin Y; Bai J; Wang M; Rosales J; Lee KY; Fu S
J Med Genet; 2015 Feb; 52(2):135-44. PubMed ID: 25537274
[TBL] [Abstract][Full Text] [Related]
35. Murine erythroleukemia cell variants: isolation of cells that have amplified the dihydrofolate reductase gene and retained the ability to be induced to differentiate.
Corin RE; Turner T; Szabo P
Biochemistry; 1986 Jul; 25(13):3768-73. PubMed ID: 3461851
[TBL] [Abstract][Full Text] [Related]
36. Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL.
Knutsen T; Mickley LA; Ried T; Green ED; du Manoir S; Schröck E; Macville M; Ning Y; Robey R; Polymeropoulos M; Torres R; Fojo T
Genes Chromosomes Cancer; 1998 Sep; 23(1):44-54. PubMed ID: 9713996
[TBL] [Abstract][Full Text] [Related]
37. Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae.
Kündig C; Leblanc E; Papadopoulou B; Ouellette M
Nucleic Acids Res; 1999 Sep; 27(18):3653-9. PubMed ID: 10471733
[TBL] [Abstract][Full Text] [Related]
38. [Mechanisms of development of resistance to methotrexate in choriocarcinoma cells].
Sakai K
Hokkaido Igaku Zasshi; 1986 Sep; 61(5):649-61. PubMed ID: 3781466
[TBL] [Abstract][Full Text] [Related]
39. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
Chao CC
FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-221 Upregulates the Expression of P-gp and Bcl-2 by Activating the Stat3 Pathway to Promote Doxorubicin Resistance in Osteosarcoma Cells.
Liu Y; Liu X; Yang S
Biol Pharm Bull; 2021 Jun; 44(6):861-868. PubMed ID: 33828027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
